PetVivo Holdings, Inc.

PetVivo Holdings, Inc. announced it received $150,000 from a partial exercise of an investor's purchase option, bringing the total equity financing to $1,150,000. In connection with this, the company issued 187,500 Units at $0.80 per Unit, with each Unit comprising one common stock share and one warrant. The investor retains an option to purchase an additional $1,350,000 in Units through July 15, 2026, with proceeds intended for product commercialization and development.

PetVivo Holdings, Inc. is conducting a private offering to raise $2,500,000 by selling Units at $0.80 each. Each Unit comprises one share of common stock and one common stock purchase warrant, with warrants exercisable at $1.10 for three years. The offering targets accredited investors, and proceeds are intended for commercialization of Spryng", new product development, clinical trials, and general corporate purposes.